.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,340,821

« Back to Dashboard

Summary for Patent: 5,340,821

Title: Composition and method for treating Sjoegren syndrome disease
Abstract:A composition for treating a Sjoegren syndrome disease is disclosed. The composition comprising derivative of spirooxathiolane-quinuclidine of the following formula (I), ##STR1## wherein Z is .dbd.CR.sup.1 R.sup.2, wherein R.sup.1 and R.sup.2 may be the same or different and each represents hydrogen, alkyl, cyclopentyl, cyclohexyl, aryl, diarylmethylol, or alkyl which may be substituted by one or more aryl groups, or an acid addition salt thereof, or an acid addition salt thereof, as an effective component. Especially effective is an administration of a hydrochloric acid addition salt of 2-methylspiro(1,3-oxathiolane-5,3')quinuclidine.
Inventor(s): Abe; Nobuaki (Tokyo, JP), Takeshita; Yasuyoshi (Utsunomiya, JP)
Assignee: Snow Brand Milk Products Co., Ltd. (JP)
Application Number:08/088,304
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent PDF download available with subscription

No matches for this query

Foreign Priority and PCT Information for Patent: 5,340,821

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan4-207485Jul 10, 1992

International Patent Family for Patent: 5,340,821

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria184483<disabled in preview>
Australia4181993<disabled in preview>
Australia666734<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc